To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
VBI Vaccines lands $50m debt financing
K2 HealthVentures has agreed to provide $50 million in debt financing to Cambridge, Massachusetts-based VBI Vaccines Inc, a developer of next-generation infectious disease and immuno-oncology vaccines.
